SEC Form 4 · accession 0001140361-15-023981
Raptor Pharmaceutical Corp · RPTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Suzanne Louise Bruhn
Director
Period of report
Jun 10, 2015
Accepted (ET)
Jun 11, 2015 · 5:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070698
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 10, 2015 | M | 30,000 | $3.33 | A | 36,695 | D | |
| Common StockF1,F2 | Jun 10, 2015 | S | 30,000 | $13.4474 | D | 6,695 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock options (right to buy)F1,F3 | $3.33 | Jun 10, 2015 | M | 30,000 | D | — | Apr 11, 2021 | Common Stock | 30,000 | 45,000 | D |
Explanation of responses
- F1Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 26, 2014.
- F2Includes 5021 Restricted Stock Units ("RSUs") granted on May 19, 2015. The Reporting Person is entitled to one (1) share of common stock for each one (1) RSU upon the vesting thereof. The RSUs vest in four equal quarterly installments with the final installment vesting no later than immediately prior to the 2016 annual meeting of stockholders.
- F3Fully vested and exercisable.